DiaSorin S.p.A.
DiaSorin S.p.A. Fundamental Analysis
DiaSorin S.p.A. (DSRLF) shows moderate financial fundamentals with a PE ratio of 16.67, profit margin of 13.15%, and ROE of 11.81%. The company generates $1.4B in annual revenue with moderate year-over-year growth of 3.20%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 50.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze DSRLF's fundamental strength across five key dimensions:
Efficiency Score
WeakDSRLF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentDSRLF trades at attractive valuation levels.
Growth Score
ModerateDSRLF shows steady but slowing expansion.
Financial Health Score
ExcellentDSRLF maintains a strong and stable balance sheet.
Profitability Score
WeakDSRLF struggles to sustain strong margins.
Key Financial Metrics
Is DSRLF Expensive or Cheap?
P/E Ratio
DSRLF trades at 16.67 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, DSRLF's PEG of 0.19 indicates potential undervaluation.
Price to Book
The market values DiaSorin S.p.A. at 2.15 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 8.09 times EBITDA. This is generally considered low.
How Well Does DSRLF Make Money?
Net Profit Margin
For every $100 in sales, DiaSorin S.p.A. keeps $13.15 as profit after all expenses.
Operating Margin
Core operations generate 28.08 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.81 in profit for every $100 of shareholder equity.
ROA
DiaSorin S.p.A. generates $6.89 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
DiaSorin S.p.A. produces operating cash flow of $207.22M, showing steady but balanced cash generation.
Free Cash Flow
DiaSorin S.p.A. produces free cash flow of $133.19M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $2.47 in free cash annually.
FCF Yield
DSRLF converts 4.46% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.67
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.19
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.15
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.09
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.50
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.37
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.12
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.18
vs 25 benchmark
How DSRLF Stacks Against Its Sector Peers
| Metric | DSRLF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.67 | 28.45 | Better (Cheaper) |
| ROE | 11.81% | 763.00% | Weak |
| Net Margin | 13.15% | -45266.00% (disorted) | Strong |
| Debt/Equity | 0.50 | 0.34 | Weak (High Leverage) |
| Current Ratio | 1.37 | 2795.60 | Neutral |
| ROA | 6.89% | -16586.00% (disorted) | Weak |
DSRLF outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews DiaSorin S.p.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
64.30%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
4.82%
Industry Style: Defensive, Growth, Innovation
GrowingFCF CAGR
51.01%
Industry Style: Defensive, Growth, Innovation
High Growth